Xcout Intel
Parallel Bio
Parallel Bio provides a human-first drug discovery and precision medicine platform that maps human biology using patient samples and computational tools. The company serves pharmaceutical and biotechnology organizations by conducting faster, animal-free preclinical testing and generating proprietary human biological data.
Subscribe to see Parallel Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Parallel Bio at a glance
Parallel Bio is a biotech company. Its most recent funding round, seed stage, raised $21M in June 2025. Xcout tracks 3 named people at Parallel Bio, including Juliana Hilliard (Co-Founder & Co-CEO). Xcout recorded 9 job postings from Parallel Bio in the last 90 days.
Parallel Bio leadership
- Juliana HilliardCo-Founder & Co-CEO
- Robert DiFazioCo-Founder & Co-CEO
- Jennifer LeeVP of Finance and Operations
Parallel Bio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| seed stage | $21M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Parallel Bio
Xcout recorded 9 job postings from Parallel Bio in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Parallel Bio's hiring signals →
Investors
Tech stack
Parallel Bio competitors
A few of Parallel Bio's closest competitors — see the full list of competitors and alternatives →
Origin is an additive manufacturing company that was acquired by Stratasys to expand its portfolio of flexible and efficient 3D printing solutions.
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Fauna Bio is a biotechnology company headquartered in Berkeley, California. The company combines animal genomics and advanced data approaches to drive drug discovery and improve human health.
Centogene AG is a company founded in 2006 and headquartered in Rostock, Germany, operating in diagnostics and drug discovery related research.
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Get Parallel Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Parallel Bio? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Parallel Bio in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access